Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
investment
Manufacturing
Grünenthal plants in South America will get $87M in upgrades
German pain relief specialist Grünenthal is investing more than 80 million euros ($87M) to update its two manufacturing facilities in South America.
Kevin Dunleavy
Jul 17, 2024 2:24pm
AstraZeneca pledges £650M in UK to expand manufacturing, R&D
Mar 6, 2024 11:38am
One year into business, RadioPharma attracts $56M series A round
Oct 17, 2023 8:05am
Berkshire Hathaway has exited stakes in AbbVie and BMS
May 17, 2022 9:25am
Merck, Roche, Teva and more make renewed pledges in Ukraine
Mar 23, 2022 10:47am
AbbVie, Lilly, Novartis cut back in Russia
Mar 16, 2022 11:51am
